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Introduction: The performance of ultrasound (US) in the diagnosis of acute gouty (MSU) arthritis and calcium
pyrophosphate (CPP) arthritis is not yet well defined. Most studies evaluated US as the basis for diagnosing crystal
arthritis in already diagnosed cases of gout and few prospective studies have been performed.
Methods: One hundred nine consecutive patients who presented an acute arthritis of suspected microcrystalline
arthritis were prospectively included. All underwent an US of the symptomatic joints(s) and of knees, ankles and
1st metatarsopalangeal (MTP) joints by a rheumatologist “blinded” to the clinical history. 92 also had standard
X-rays. Crystal identification was the gold standard.
Results: Fifty-one patients had MSU, 28 CPP and 9 had both crystals by microscopic analysis. No crystals were
detected in 21. One had septic arthritis. Based on US signs in the symptomatic joint, the sensitivity of US for both
gout and CPP was low (60 % for both). In gout, the presence of US signs in the symptomatic joint was highly
predictive of the diagnosis (PPV = 92 %). When US diagnosis was based on an examination of multiple joints, the
sensitivity for both gout and CPP rose significantly but the specificity and the PPV decreased. In the absence of US
signs in all the joints studied, CPP arthritis was unlikely (NPV = 87 %) particularly in patients with no previous crisis
(NPV = 94 %). X-ray of the symptomatic joints was confirmed to be not useful in diagnosing gout and was equally
sensitive or specific as US in CPP arthritis.
Conclusions: Arthrocenthesis remains the key investigation for the diagnosis of microcrystalline acute arthritis.
Although US can help in the diagnostic process, its diagnostic performance is only moderate. US should not be
limited to the symptomatic joint. Examination of multiple joints gives a better diagnostic sensitivity but lower
specificity.Introduction
The gold standard for diagnosing gout (monosodium
urate (MSU) arthritis) and calcium pyrophosphate (CPP)
arthritis is the identification of crystals in joint fluid [1].
In an acute setting, the sensitivity of crystal identification
has been proven to be very high (>90 %), particularly in
gout [2, 3]. The performance of this technique is not
perfect, however, especially in patients with chronic
arthritis and in asymptomatic joints.
Joint aspiration is not always possible, so alternative
diagnostic tools have been proposed [4]. These alterna-
tive tools include clinical scores [5, 6], ultrasonography
[7], magnetic resonance imaging (MRI) [8] and dual-* Correspondence: Pascal.zufferey@chuv.ch
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creativecommons.org/publicdomain/zero/1.0/energy computed tomography (DECT) [8, 9]. Ultrasound
(US) features of gouty and CPP arthritis have been well
described [5, 8, 10, 11], and the technique has been pro-
posed as a convenient diagnostic tool for crystal-induced
arthritis [12]. Although the typical US signs of MSU and
CPP are well defined [10, 13–17], the accuracy (or reli-
ability) of the technique remains not totally clear. In-
deed, the sensitivity (40–95 %) or the specificity (60–
95 %) of US for diagnosing both MSU and CPP varied
considerably from one study to the other [8, 17, 18].
These differences have several origins: the quality of the
equipment, which has greatly improved in the last
5 years; the progressively better recognition of pitfalls, in
particular of the double contour sign [19]; the status of
the disease (longstanding, acute, chronic) [20, 21]; the
type and number of joints examined; the quality of the
gold standard (crystal detection in joint aspirate) [3]; andticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise credited.
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Moreover, there have been only a limited number of pro-
spective studies on the performance of US as a diagnostic
tool when applied to the setting of acute arthritis [22, 23]
in real-life practice. Most US studies have been performed
in patients with established disease [22, 24–26].
The primary objective of our study was to assess the
performance of US as a diagnostic tool for CPP and
MSU in acute crystal arthritis, using crystal identifica-
tion by microscopy as a gold standard.
The secondary objective was to compare US with
X-ray imaging in terms of diagnostic performance.
Methods
Selection of patients
We conducted a single-centre prospective study. One
hundred and twelve consecutive patients who presented
with acute arthritis of suspected microcrystalline origin
were included in the study between October 2012 and
May 2014. Clinical suspicion of crystal-induced arthritis
was based on the following criteria: an acute onset
(<10 days duration), swelling of one or few joints (up to
three), local and or systemic signs and symptoms of in-
flammation, and absence of a known diagnosis of inflam-
matory rheumatic disease such as rheumatoid arthritis,
spondyloarthritis or connective tissue disease. Our local
ethical committee (Commission d’éthique de la recherche
sur l’être humain (CER-VD)) approved the study. Consent
to participate to the study was obtained from all patients.
Clinical data
For each patient, we collected demographic data, history
of comorbidities known to be associated with gout
(metabolic syndrome, renal impairment, medications
that induce hyperuricemia, cardiovascular disease) and
CPP (renal insufficiency, calcium/phosphate abnormalities,
hypothyroidism). We also recorded previous history of
arthritis flares. Because the duration of the illness reflected
by previous crisis was suspected to be an important factor
influencing the development of US signs, we performed a
subset analysis, stratifying the patients into two groups: the
former with previous crisis of CCP or MSU arthritis, the
latter with none. We also recorded a detailed description
of the current clinical presentation: number and localisa-
tion of symptomatic joints, duration of symptoms, local
and systemic clinical signs such as joint temperature and/
or redness presence of extra-articular tophi, C-reactive
protein (CRP), uric acid blood levels, ongoing treatments
for the current flare, and change in treatment induced by
analysis of the synovial fluid.
Ultrasound
All patients underwent US of the symptomatic joint as well
as both knees, ankles and the first metatarsophalangeal(MTP) joints. Each joint was explored using both longitu-
dinal dorsal and lateral approaches. In the knee, a trans-
versal supra-patellar view in maximal flexion was also
performed to better examine the condylar cartilage. The
machines used were either a Philips HD11 or an Esaote
My-lab 70 philips: Best, Netherland Easote. Genoa, Italy.
The type of probe was adapted to the size of the joint
(from 9 to 18 MHz).
US diagnosis was evaluated based on typical US signs
[11, 24]. For gout, we took into account the ‘double con-
tour sign’ (Fig. 1a) and/or the presence of tophi, defined
as a non-homogeneous mass that could be hypoechoic
or hyperechoic, surrounded by a small anechoic rim
(Fig. 1b). Hyperechogenic spots considered as aggre-
gates of crystals were not considered. For CPP, intra-
cartilage (Fig. 1c), meniscus (Fig. 1d), synovial or tendon
hyperechoic deposits were considered diagnostic. Other
US signs not necessarily relevant for the diagnosis were
also recorded. They included erosions, osteophytes and
Doppler activity in the synovium or around tophi.
Symptomatic joints were examined first, followed by all
other joints.
Two rheumatologists who were not aware of the clinical
history or examination performed all US examinations.
One rheumatologist has over 15 years of experience, and
the other 2 years of experience. To determine the inter-
observer agreement, the first 10 patients were examined
in common by the two operators.
Joints aspiration and examination
Joint aspiration for microbiology and crystal analysis was
performed on the symptomatic joints. Many of the aspi-
rations were carried out under US guidance, especially
when small joints were symptomatic or when little syn-
ovial fluid was present. US and joint aspiration were per-
formed usually at the same time, but at most within
24 hours of each other.
Identification of crystals was based on crystal birefrin-
gence and crystal morphology. Only intracellular crystals
were taken into account for diagnosis. The diagnosis was
confirmed by two different observers (one directly after
the puncture by the clinician; the other a technician in the
laboratory dedicated to joint fluid analysis). In the labora-
tory, the fluid was first centrifuged in order to enhance the
concentration of cells and of potential crystals. In the 10
cases where the amount of liquid was too small to be sent
to the laboratory, the diagnosis was only based on clinician
observation. In three cases of disagreement between the
two observers, the laboratory diagnosis was retained.
A synovial fluid culture was also performed in each
case to exclude septic arthritis. When the amount of
fluid was adequate, a numeration of leukocytes was also
performed to confirm the inflammatory nature of the
acute flare.
Fig. 1 Gout signs: a double contour signs and b tophus. CPP signs: c linear hyperechoic deposit inside the cartilage and d in the meniscus
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X-ray imaging were recommended but not mandatory.
Available X-ray imaging at the time of the acute attack
were compared with US findings. Symptomatic and non-
symptomatic joints were analysed separately. X-ray imaging
were reviewed in consensus by two different rheumatolo-
gists as well as a musculoskeletal radiologist, all blinded to
the final diagnosis. Radiological signs of gout were well-
defined juxta-articular sclerotic erosions ± localised soft
tissue swelling compatible with tophi, and CPP signs were
linear radiopaque deposits projecting on articular soft
tissues, in particular the cartilage, meniscus, tendons or
synovium.
Statistical analysis
Results for quantitative clinical and demographic vari-
ables are reported as the mean ± standard deviation, and
results for qualitative variables as numbers or per-
centages per category. The groups were compared by
univariate logistic regression. P <0.05 was considered
significant.
US and X-ray diagnoses were considered as index
tests, with crystal identification in the fluid analysis con-
sidered the referent test for the diagnosis. The per-
formance of US and X-ray imaging was evaluated by
assessing the sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) on
symptomatic joints and also in all joints. Tests were per-
formed using statistical software (MedCalc Software,
Ostend, Belgium).Results
Clinical and demographic data
One hundred and twelve patients fulfilled the inclusion
criteria; 109 of these were eventually analysed after the
exclusion of three patients due to the absence of fluid on
puncture. The demographic data for the 109 remaining
patients are summarised in Table 1. Sixty-two patients
had monoarthritis and 47 had oligoarthritis. Monoarthri-
tis was more frequent in patients with CPP arthritis
(Table 1). Patients were predominately older males in all
groups. In 40 % of MSU and in 70 % of CPP diagnosed
arthritis cases, the presenting attack was the first re-
ported symptomatic episode of crystal arthritis. There
were a high number of comorbidities but not of the
same type in gout and non-gout patients (more cardio-
vascular diseases, hyperlipidaemia, diabetes in gout pa-
tients against more renal insufficiency, hypothyroidism
in CPP patients). The mean CRP was elevated in all
groups but was significantly higher in gout patients
(Table 1). This was also the case for serum uric acid
levels measured at the time of the attack.
Puncture and fluid analysis
Results of crystal analysis in the fluid aspirations are
decrypted in Fig. 2. MSU crystals were found in 51 pa-
tients and CPP crystals in 28 patients. Twenty-one pa-
tients had no crystals. Both MSU and CPP crystals were
detected in the same symptomatic joint in nine patients.
In these subjects it was impossible to determine which
crystal was responsible for the acute flare, so we added
Table 1 Demographic and clinical data for the patients
according to the diagnosis based on the analysis of joint fluid
MSU
(n = 60)a
CPP
(n = 37)a
No crystals
(n = 21)
P value
Sex (% male) 92 68 79 NS
Age (years),
mean (SD)
65 (12) 75 (15) 67 (10) NS
First attack
of arthritis (%)
41 70 67 NS
Monoarticular
arthritis (n)
31 26 11 <0.05b,c
Oligoarticular
arthritis (n)
29 11 10 <0.05*
CRP (mg/l), mean,
n = 10 mg/l (SD)
108 (77) 76 (84) 46 (42) <0.05d
Urate (μmol/l),
mean (SD)
477 (160) 335 (113) 390 (131) <0.05e
CPP calcium pyrophosphate, CRP C-reactive protein, MSU monosodium urate,
NS not significant, SD standard deviation
aIt was hard to determine which crystal was responsible for the acute flare, so
the nine patients with both crystals were added to both the MSU (gout) and
CPP (chondrocalcinosis) groups
bNo crystal versus CPP and MSU
cCCP versus gout and no crystal
dNo crystal versus gout
eCCP versus gout
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n = 37; no crystal, n = 21).
The knee was the most common symptomatic joint,
followed by the metatarsal, the ankle joint and the wrist.
Crystals were also most frequently identified thanks to
fluid aspiration in the knees for both MSU arthritis
(27/60 positive cases) and CPP arthritis (22/37 positive
cases). The latter crystal was never found in the firstFig. 2 Distribution of the patients according to crystal fluid analysis. CPP caMTP joints, contrary to MSU crystals. A movie file
shows this in more detail (see Additional file 1).
The design of the study did not permit collection of
supplementary investigations and follow-up in the 21 pa-
tients without crystals. At the time of joint aspiration,
the diagnosis of a non-specific inflammatory arthritis
was retained in 12 of these patients, based on the syn-
ovial white cell count. Microbiology was negative except
for one patient who was treated for septic arthritis. In
this patient, joint fluid aspiration did not reveal any crys-
tals and no US signs of MSU or CPP arthritis were de-
tected. Three patients had a non-inflammatory fluid
collection.
Ultrasound
US signs of microcrystalline arthritis (MSU and/or CPP)
were present in 65/88 patients with crystals detected in
the joint aspirations (sensitivity of 74 %), and only in
3/21 patients with no crystals identified (specificity of
82 %).
The utility of US signs for the diagnosis of MSU and
CPP arthritis was evaluated separately: firstly by consid-
ering the presence of US signs for each form of arthritis
in the presenting symptomatic joint only; and secondly
by the presence of US signs in all joints examined.
When the analysis was limited to US signs in the target
joints, the sensitivity of US for gout was 60 % (44 % for
‘double contour’ only) and also 60 % for CPP arthritis.
When US signs of other joints were taken into account,
the US sensitivity for MSU rose from 60 to 84 % and for
CPP from 60 to 81 %. However, the specificity went down
from 92 to 78 % for gout and from 80 to 62 % for CPP
(Table 2).lcium pyrophosphate, MSU monosodium urate
Table 2 Sensitivity, specificity, positive predictive value and
negative predictive value of ultrasound signs for MSU and
CPP arthritis
MSU
symptomatic
joint
MSU
multiple
joints
CPP
symptomatic
joint
CPP
multiple
joints
Sensitivity (%) 60 84 60 81
Specificity (%) 92 78 80 62
Positive
predictive
value (%)
92 82 60 52
Negative
predictive
value (%)
62 77 80 87
The nine patients with both crystals were added to both the MSU and
CPP groups
CPP calcium pyrophosphate, MSU monosodium urate
Table 3 Frequency of ultrasound signs in patients according to
the joints examined
Joint localisation of ultrasound signs
(number/joint)a
Knee MTP Wrist Ankle Hand Others
Gout confirmed (60 patients)
Symptomatic joints
MSU signs 10 38 0 9 1 0
CPP signs 13 2 0 1 1 0
Asymptomatic jointsb
MSU signs 10 32 9
CPP signs 12 5 3
CPP confirmed (37 patients)
Symptomatic joints
CPP signs 22 1 4 1 1 0
MSU signs 0 5 3
Asymptomatic joints
CPP signs 15 7 1
MSU signs 0 7 3
No crystals (21 patients)
Symptomatic joints
MSU sign 0 2 0 0 0 0
CPP sign 3 1 2 0 0 0
Asymptomatic joints
MSU signs 0 3 0 0
CPP signs 5 3 1 0
CPP calcium pyrophosphate, MSU monosodium urate, MTP metatarsophalangeal
joint
aFor some patients several joints were symptomatic, so the number of joints is
larger than the number of patients
bFor some patients signs were present on symptomatic and asymptomatic
joints, so the number of joints is larger than the number of patients
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symptomatic joint, gouty arthritis was highly probable
(PPV >90 %). This was not the case for CPP (PPV = 60 %).
In the absence of any US signs of CPP after multiple
joints examination, CPP arthritis was unlikely (NPV =
87 %). This was less in the case of gout (NPV = 77 %)
(Table 2).
The sensitivity and the PPV of US limited to the symp-
tomatic joints for both MSU and CCP were not signifi-
cantly influenced by a history of previous crisis. A file
shows this in more detail (see Additional file 2). The
performances of multiple joint examinations were en-
hanced (see Additional file 2). However, only in patients
with no previous history of CCP arthritis could the ab-
sence of US signs rule out CCP diagnosis (NPV = 94 %
against 50 % in absence of previous crisis).
The first MTP joint was the most common site of US
signs for gout in symptomatic and asymptomatic joints
(Table 3). For CPP, most of the signs were present essen-
tially in the knees and in the wrists. US CPP signs of
crystal deposition especially in the knee were present
in many patients with no CPP crystal-proven arthritis
(Table 3), explaining the low specificity of US in
chondrocalcinosis.
In the subgroup of patients (n = 9) with both crystals,
US was of little help in the differential diagnosis between
CPP and MSU arthritis. US signs of both diseases were
present in symptomatic joints of three patients, MSU
signs only in two patients and CPP signs in four patients.
When US was performed on multiple joints, all patients
had US signs of at least one or both diseases.
X-ray imaging
X-ray imaging of the affected joint were not mandatory
for this study. Eighty of 109 patients had an X-ray scan
of the symptomatic joint and 92/109 patients had X-ray
imaging for at least one of the other asymptomatic jointsevaluated by US. In gout patients (40 patients), X-ray
imaging of the symptomatic joints was confirmed not to
be useful because of the very poor sensitivity and NPV
(see Table 4).
In CPP arthritis, the performance of X-ray and US im-
aging on the symptomatic joints in the 29 patients for
whom both procedures were available were similar: sensi-
tivity of 55 % versus 63 %, and specificity of 82 % versus
90 % respectively. As the US results matched those of the
overall cohort (Table 2), the performance of X-ray imaging
can be to could be extrapolate to the entire cohort.
Adding X-ray imaging of additional joints did not
change significantly the sensitivity or the specificity for
both CPP and MSU arthritis (Table 4). Because the
number and the localisation of additional joints exam-
ined by radiography were not always similar, it was im-
possible to strictly compare the performance of X-ray
imaging and US.
Table 4 Sensitivity, specificity, positive predictive value and
negative predictive value of X-ray imaging for MSU and
CPP arthritis
MSU
symptomatic
joint
MSU
multiple
joints
CPP
symptomatic
joint
CPP
multiple
joints
Sensitivity (%) 5.6 19 55 58
Specificity (%) 100 100 82 79
Positive
predictive
value (%)
100 100 65 64
Negative
predictive
value (%)
53.8 55 77 78
The nine patients with both crystals were added to both the MSU and
CPP groups
CPP calcium pyrophosphate, MSU monosodium urate
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in the joint fluid, 4/6 patients had radiographic signs of
chondrocalcinosis.
Discussion
The primary objective of our study was to determine
whether the diagnostic performance of US was suffi-
ciently good to allow the clinician to skip joint aspiration
and crystal identification by microscopy in order to
make a diagnosis of microcrystal-induced arthritis. This
situation is frequently encountered in clinical practice in
the primary or secondary care setting and we designed
our study to fit as closely as possible these real-life
conditions.
Our results showed that US signs of either MSU or
CPP alone are not sensitive enough as a diagnostic tool.
When US was limited to the symptomatic joints, its sen-
sitivity was only around 60 %. However, when US signs
of gout were present they were highly predictive of the
diagnosis of MSU arthritis (PPV = 92 %). This was much
less the case for acute CPP arthritis. Indeed, on the con-
trary to MSU arthritis, the positive predictive value of US
CPP signs in the symptomatic joints was low (PPV = 60 %).
This could be partially explained by the high prevalence of
chondrocalcinosis in our patients, who were by and large
an older population.
By examining non-symptomatic joints as part of the
US examination, the sensitivity of the test was enhanced
but the specificity decreased. In CPP arthritis, when no
US signs were found after examination of all the pre-
specified joints, the disease could be reasonably ruled
out (NPV = 87 %). The same result has been confirmed
by other groups using the same approach, suggesting
that US examination should not be limited to symptom-
atic joints only [25]. However, there is still no consensus
on which additional joints should be scanned. According
to our study and the literature, examination of the kneeis mandatory for CPP arthritis [20] and the MTP joint
for MSU. Some studies suggest that the wrist should also
be examined [16].
The justification for requesting an X-ray scan of the
symptomatic joint when one suspects an acute micro-
crystalline arthritis is debatable. Our study confirmed
that X-ray imaging has no place as a diagnostic tool for
MSU arthritis [27, 28] and does not perform better than
US for CPP [11]. In this latter situation, we think that
US should be the first—and in most settings the unique—
imaging modality, as suggested by other authors [11].
Our results need some additional comments with re-
gard to their interpretation and the study has some limi-
tations. Owing to our study design, no definite diagnosis
of non-crystal arthritis could be assigned in 20 % of the
cases. We cannot rule out that some of these patients in
this group indeed had a microcrystalline arthritis (either
MSU or CCP arthritis) that could have been confirmed
if followed up, as demonstrated in some studies [14].
The diagnostic performance of US for microcrystalline
arthritis appears to be lower in our study than in some
recent publications [16]. This difference can partly be
explained by the duration of the illness. Indeed, in many
of our patients the acute arthritis was the first flare and
it is known that typical US signs accumulate in the
course of the disease for either MSU or CPP disease.
This was only partially confirmed when we stratified our
patients according to the presence or not of previous
crisis. For MSU, we were also strict in the interpretation
of a positive ‘double contour’ sign. This sign was
retained only when the hyperechoic deposit was irregu-
lar and present not only directly perpendicular under
the probe but independent from the insonation angle
in order to differentiate from reinforcement artefacts.
Moreover, hyperechogenic spots—considered by some
authors as aggregates of MSU crystals—were not taken
into account because this sign is not yet confirmed to be
specific for MSU arthritis [29, 30].
Although two different clinicians looked for the pres-
ence of crystals, we cannot exclude some cases of de-
tection errors, which would partially explain the low
sensitivity, especially for CPP (see Table 4). Previously, a
high sensitivity of US for CPP had been demonstrated
essentially for the knee joint [10], but in our study al-
most one-half of the symptomatic CPP flares concerned
other joints. We also had a low number of controls with-
out crystals compared with other studies due to the pro-
file of the study including patients with a high suspicion
of microcrystalline disease. This selection and the quite
elevated mean age of the patients certainly explained
why we found both crystals in nine of them, essentially
in the knee where the prevalence of symptomatic and/or
asymptomatic chondrocalcinosis is high. Finally, the
advances in US technology will certainly improve to
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the sensitivity of US for microcrystalline arthritis, thanks
to higher frequency probes and optimisation of the
software.
The treatment for an acute flare of CPP [31] and MSU
[32] arthritis is in most cases very similar, and therefore
the absolute necessity of a precise diagnosis for initiating
an immediate treatment strategy is not critical [3, 7].
This remark applies also to the patients with signs of
both conditions at US and even on synovial fluid ana-
lysis. In our study, however, we found one case of septic
arthritis with no US signs of microcrystalline arthropa-
thy. In the very acute phase, there are unfortunately no
clinical, US or radiological elements can that can clearly
differentiate septic arthritis from microcrystalline arth-
ritis [33]. Joint aspiration therefore remains, for us, abso-
lutely necessary when septic arthritis is suspected. If the
clinician decides to start, based on US data, a treatment
for crystal arthritis without a joint puncture, the patient
should be carefully followed up and this attitude should
be rapidly revised in the case of a non-response.Conclusions
Our study confirms that arthrocentesis remains the key
investigation for the diagnosis of microcrystalline acute
arthritis. The exact place of US in the diagnosis of acute
microcrystalline arthritis is still not well defined [30].
The results of our study suggest that US is much more
useful than X-ray imaging. US can be a real help for
puncture in small joints and could serve as an alterna-
tive procedure, in case of impossibility or contraindica-
tion to joint aspiration. The presence of MSU signs on
the symptomatic joint is highly suggestive for the diag-
nosis of gout. US should not, however, be limited to the
symptomatic joint. US of multiple joints give a better
diagnostic sensitivity but lower specificity. In the absence
of US signs of CPP on multiple joint US, it is highly un-
likely that arthritis is due to CPP in patients with no pre-
vious history of such disease.Additional files
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